Furthermore, we showed that the MEK inhibitor, U0126, abrogated HA-induced migration, restoring the baseline condition levels, in agreement with previous reports that demonstrated the involvement of the MEK/ERK pathway in the HA-induced migration in other tumor cell lines [14, 47–49]. The gene discussed is MAP2K7; the disease is neoplasm.